fda compounding semaglutide update The is proposing the removal of three GLP-1 drugs from the 503B bulks list of active ingredients that outsourcing facilities can use to make compounded medicines, the agency announced on Thursday Compounded Semaglutide: Legal & Safe

Differences in Characteristics and Complications for GLP-1 Users Patients taking GLP-1 medications were more likely to have comorbidities including type 2 diabetes, hypertension, and chronic obstructive pulmonary disease, although body mass index was similar between groups

Getting it wrong doesn't just waste a vial

Dissected gonads were incubated in 20 mg/ml Pronase to segregate DTCs (Merck Millipore, 537088)

they represent a reproducible pattern across multiple substances and multiple study designs

Current Medicinal Chemistry

Thus, we speculated that T3 might regulate GLP-1 production in a cell-nonautonomous manner